Prof. Richard Rosenquist shares insights on the clinical use of whole-genome and transcriptome sequencing (WGTS) in acute leukemias. In this 5‑minute interview, he highlights how WGTS can streamline workflows, improve diagnostic yield, and identify clinically actionable findings in AML and ALL. Drawing on his experience implementing WGTS in routine testing and at a national level, he discusses its growing role in supporting more confident and precise clinical decision-making. Richard Rosenquist, MD, PhD, is Professor and Senior Physician in Clinical Genetics at Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden, and Director of Genomic Medicine Sweden (GMS). #WGTS #Leukemia #AML #ALL #HemeOnc #Pathology #Diagnostics Subscribe to the Illumina video channel http://www.youtube.com/subscription_center?add_user=IlluminaInc A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond. View customer spotlight videos https://www.youtube.com/playlist?list=PLKRu7cmBQlajfheLzgbI4S7xBn7IDbt79 View Illumina webinars https://www.youtube.com/playlist?list=PLKRu7cmBQlahpXlnrrXlQw9itVJ8yHwUZ View Illumina support videos https://www.youtube.com/playlist?list=PLKRu7cmBQlajbm2KGsICWb-JOnusJfYvM LinkedIn: https://www.linkedin.com/company/illumina X: https://x.com/illumina Instagram: https://www.instagram.com/illuminainc/ Facebook: https://www.facebook.com/illuminainc TikTok: https://www.tiktok.com/@illuminainc